Clinical Trial Update: A Study of Duloxetine (LY248686) in Japanese Children and Adolescents With Depressive Disorder [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of duloxetine (LY248686) in Japanese children and adolescents with depressive disorder has completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder

Drugs mentioned

• Duloxetine (DULOXETINE)

Snippet

Sponsor: Shionogi | Conditions: Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2021-01-05